Health Care: Drugs

Hyperion Therapeutics Inc (HPTX: NASDAQ)

$25.3 n/a | n/a%
01/30/15 - 04:00 PM ET
Company Cash Flow
Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) 16.63M -32.26M -29.42M
Operating Gains/Losses 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00
(Increase) Decrease In Receivables -4.43M 0.00 0.00
(Increase) Decrease in Inventories 468.00K 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00
(Decrease) Increase In Payables 115.00K 290.00K 1.20M
(Decrease) Increase In Other Current Liabilities 9.65M 1.26M 1.37M
(Increase) Decrease In Other Working Capital 81.00K -114.00K 123.00K
Other Non-Cash Items -26.77M 1.04M 1.07M
Net Cash From Continuing Operations -1.21M -28.53M -24.53M
Net Cash From Discontinued Operations 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -1.21M -28.53M -24.53M
Sale of Property, Plant & Equipment 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -1.08M -328.00K -8.00K
Acquisitions 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00
Other Cash from Investing Activities 10.96M 330.00K -4.00K
Cash Provided by Financing Activities
Net Cash From Investing Activities -34.05M 2.00K -12.00K
Issuance of Debt 0.00 19.90M 24.98M
Cash Used for Financing Activities
Issuance of Capital Stock 65.12M 53.62M 0.00
Repayment of Long-Term Debt -4.35M 0.00 0.00
Repurchase of Capital Stock 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00
Other Financing Charges, Net -1.13M -2.16M 0.00
Net Cash From Financing Activities 59.64M 71.36M 24.98M
Effect of Exchange Rate Changes 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents 24.38M 42.84M 439.00K

Portfolios with HPTX

Latest HPTX Headlines from TheStreet

More Financial News for HPTX

Press Releases for HPTX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter